NCT03056638View on ClinicalTrials.gov

Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

August 16, 2023

Study Completion Date

August 16, 2023

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

Degarelix monthly for 6 months

RADIATION

stereotactic body radiosurgery (SBRT)

SBRT 8 Gy x 5

Trial Locations (10)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11553

Memorial Sloan Kettering Nassau, Uniondale

11570

Memorial Sloan Kettering Rockville Centre, Rockville Centre

11725

Memorial Sloan Kettering Commack, Commack

18103

Lehigh Valley Health Network, Allentown

33143

Baptist Alliance MCI, Miami

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

07645

Memorial Sloan Kettering Bergen, Montvale

Sponsors

Collaborators (1)

Ferring Pharmaceuticals
All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

University of Michigan

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER